Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis C NS3-4A protease using structure-based drug design

被引：30

作者：

Venkatraman, S ^{[1
]}

Njoroge, FG ^{[1
]}

Girijavallabhan, VM ^{[1
]}

Madison, VS ^{[1
]}

Yao, NH ^{[1
]}

Prongay, AJ ^{[1
]}

Butkiewicz, N ^{[1
]}

Pichardo, J ^{[1
]}

机构：

[1] Schering Plough Res Inst, Kenilworth, NJ 07033 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 16期

关键词：

D O I：

10.1021/jm0489556

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Hepatitus C virus (HCV) NS3, when bound to NS-4A cofactor, facilitates development of mature virons by catalyzing cleavage of a polyprotein to form functional and structural proteins of HCV. The enzyme has a shallow binding pocket at the catalytic site, making development of inhibitors difficult. We have designed, preorganized, and depeptidized macrocyclic inhibitors from P-4 to P-2' and optimized binding to 0.1 mu M. The structure of an inhibitor bound to the enzyme was also solved.

引用

页码：5088 / 5091

页数：4

共 50 条

[1] Design and synthesis of depeptidized P2-P4 biaryl macrocyclic inhibitors of hepatitis-C NS3-4A protease
Venkatraman, S
Njoroge, FG
Girijavallabhan, V
Madison, V
Ya, N
Prongay, A
Butkiewicz, N
Pichardo, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2605 - U2605
[2] Advances in the Development of Macrocyclic Inhibitors of Hepatitis C Virus NS3-4A Protease
Avolio, Salvatore
Summa, Vincenzo
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (14) : 1403 - 1422
[3] Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus
Frecer, V
Kabelác, M
De Nardi, P
Pricl, S
Miertus, S
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2004, 22 (03): : 209 - 220
[4] The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase
Attwood, MR
Bennett, JM
Campbell, AD
Canning, GGM
Carr, MG
Conway, E
Dunsdon, RM
Greening, JR
Jones, PS
Kay, PB
Handa, BK
Hurst, DN
Jennings, NS
Jordan, S
Keech, E
O'Brien, MA
Overton, HH
King-Underwood, J
Raynham, TM
Stenson, KP
Wilkinson, CS
Wilkinson, TCI
Wilson, FX
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1999, 10 (05): : 259 - 273
[5] QSAR-BASED MODELLING OF MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3-4A SERINE PROTEASE
Srivastava, A. K.
Pandey, A.
OXIDATION COMMUNICATIONS, 2011, 34 (01): : 108 - 116
[6] Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors
Namoto, Kenji
Sirockin, Finton
Sellner, Holger
Wiesmann, Christian
Villard, Frederic
Moreau, Robert J.
Valeur, Eric
Paulding, Stephanie C.
Schleeger, Simone
Schipp, Kathrin
Loup, Joachim
Andrews, Lori
Swale, Ryann
Robinson, Michael
Farady, Christopher J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 906 - 909
[7] P2-P4 macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease
Arasappan, Ashok
Njoroge, F. George
Chen, Kevin X.
Venkatraman, Srikanth
Parekh, Tejal N.
Gu, Haining
Pichardo, John
Butkiewicz, Nancy
Prongay, Andrew
Madison, Vincent
Girijavallabhan, Viyyoor
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (15) : 3960 - 3965
[8] Effect of combining helicase and protease inhibitors on hepatitis C NS3-4A
Corby, M. J.
Ndjomou, J.
Frick, David N.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[9] Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease
Parsy, Christophe
Alexandre, Francois-Rene
Brandt, Guillaume
Caillet, Catherine
Cappelle, Sylvie
Chaves, Dominique
Convard, Thierry
Derock, Michel
Gloux, Damien
Griffon, Yann
Lallos, Lisa
Leroy, Frederic
Liuzzi, Michel
Loi, Anna-Giulia
Moulat, Laure
Musiu, Chiara
Rahali, Houcine
Roques, Virginie
Seifer, Maria
Standring, David
Surleraux, Dominique
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (18) : 4444 - 4449
[10] Arresting AIDS and halting hepatitis C: Structure-based design of protease inhibitors
Holloway, M. Katharine
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244

← 1 2 3 4 5 →